CUTISS AG-preview

Cutiss

CUTISS AG

Private

SchlierenHealthcare & Life Scienceshttps://cutiss.swiss

Last Round

Series C

Sep 10, 2025

Total Funding Raised

$97.89M

Momentum Score

50 /100

Company Overview

CUTISS AG is a Swiss life sciences company that develops personalized, bio-engineered skin grafts to treat large and deep skin defects.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Smart Manufacturing, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

tissue engineeringregenerative medicinepersonalized skin graftslab-grown skinburn treatmentautologous skin graftcell therapyskin regenerationskin substitutesartificial skinscar reductionautomated manufacturingAdvanced Therapy Medicinal ProductATMPvitiligo treatmentOrphan Drug Designationreconstructive surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CUTISS AG Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CUTISS AG Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Sep 10, 2025
Grant	May 1, 2023
Series B	Jun 29, 2020
Grant	Aug 19, 2019
Grant	Sep 1, 2018
Series A	Jun 20, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Daniela Marino

Chief Executive Officer

Executive Team

Anke Ness

Interim CFO

Executive Team

CUTISS AG Investors

Notable investors and investment history

Investor	Rounds
Horizon 2020	Grant
Yellowstone Holding AG	Series A
Swisspreneur Syndicate	Series C
Wyss Foundation	Series B
Zurcher Kantonalbank	Series A
Shiloh Advisors AG	Series C
Innosuisse	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 20, 2026
Launched a process for manufacturing personalized, living skin.
Oct 1, 2025
denovoSkin™ successfully completed Phase I clinical trials in burns patients.

View all signals

CUTISS AG Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CUTISS AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CUTISS AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren

Employee Range59

Year Founded2017

Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.